Last reviewed · How we verify

Chlorhexidine, Mupirocin — Competitive Intelligence Brief

Chlorhexidine, Mupirocin (Chlorhexidine, Mupirocin) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical antimicrobial combination. Area: Dermatology / Infection Prevention.

marketed Topical antimicrobial combination Bacterial cell membrane (chlorhexidine); isoleucyl-tRNA synthetase (mupirocin) Dermatology / Infection Prevention Small molecule Live · refreshed every 30 min

Target snapshot

Chlorhexidine, Mupirocin (Chlorhexidine, Mupirocin) — University of Tennessee. This combination of chlorhexidine and mupirocin works by disrupting bacterial cell membranes and inhibiting bacterial protein synthesis to prevent and treat skin infections.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Chlorhexidine, Mupirocin TARGET Chlorhexidine, Mupirocin University of Tennessee marketed Topical antimicrobial combination Bacterial cell membrane (chlorhexidine); isoleucyl-tRNA synthetase (mupirocin)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical antimicrobial combination class)

  1. University of Tennessee · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Chlorhexidine, Mupirocin — Competitive Intelligence Brief. https://druglandscape.com/ci/chlorhexidine-mupirocin. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: